The ASMT gene helps your body make melatonin, the hormone that supports your sleep-wake cycle. It carries out the last step in changing serotonin into melatonin, mainly in the pineal gland, a small part of the brain involved in body timing. If the ASMT gene does not work properly, melatonin production can drop, which may affect sleep timing and sleep quality.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes provide the information needed to make proteins, which are the working parts of cells. Other genes mainly regulate when certain processes happen, where they occur, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
ASMTGene function
What if the gene works
The ASMT gene helps your body make melatonin, a hormone that supports your sleep-wake cycle. It carries out the last step in melatonin production, mainly in the pineal gland.
Risk
What if the gene does not work
If the ASMT gene works less well, cells may complete the final step of making melatonin less efficiently. Milder variants may partly reduce this activity, while more severe variants can lower it further.
Treatment
What does that mean for your treatment
No treatment or management approach specific to pathogenic variants in the ASMT gene is currently established in clinical guidelines. The ASMT gene is being studied within the melatonin pathway in sleep and neurodevelopment research, but this has not yet changed routine drug choices.
Gene function
What if the gene works
Your body uses the ASMT gene in the last step of making melatonin. It turns N-acetylserotonin, a serotonin-related substance, into melatonin, which signals nighttime to the body. This background helps explain how daily sleep timing stays coordinated.
Inside your cells, the ASMT gene performs the final step needed to make melatonin. It adds a small chemical tag to N-acetylserotonin so melatonin can be formed.
The melatonin made with help from this gene acts as a time cue that tells the body it is night. This is a key part of how the ASMT gene helps make melatonin for the sleep-wake cycle.
By supporting melatonin production, this gene helps align daily rhythms such as sleep timing and changes in alertness. Its activity fits into the body's internal clock system, which coordinates routines over about 24 hours.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and help create normal variation among people, such as in appearance, metabolism, or the way the body reacts to environmental factors. Many variants do not cause any noticeable changes and are simply part of natural genetic diversity. Sometimes, though, a variant changes how a gene works to a greater extent and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ASMT gene can change the enzyme's shape, stability, or how well it binds its chemical target, which may lower its activity. In discussions of ASMT gene variants and melatonin production, milder changes may partly reduce this final-step enzyme activity, while more disruptive variants can leave little or no activity. Some variants also affect how much ASMT protein a cell makes.
How variants are linked to conditions
Current evidence has not established a broadly confirmed pattern of ASMT gene variants linked to specific conditions, although research continues to explore possible connections. Reported associations in studies have been inconsistent and are not used on their own to define a specific ASMT related diagnosis. Anyone with a confirmed ASMT finding should follow advice from their doctor or genetic counselor for personal interpretation.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially in conditions influenced by multiple genes and environmental factors. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce health risk related to the ASMT gene. Changes in ASMT may be one small part of a bigger picture that also includes other genes and everyday factors such as sleep habits, overall health, and environment. Anyone concerned about personal risk should speak with a doctor or genetic counselor.
Inheritance of ASMT variants
Information on how ASMT gene variants are inherited is still developing, and there is not yet a broadly confirmed Mendelian inheritance pattern tied to a specific ASMT related condition. The ASMT gene sits in the pseudoautosomal region shared by the X and Y chromosomes, rather than following the usual pattern for genes found only on one sex chromosome. In practical terms, this means an ASMT gene copy can be passed from either parent to a child of any sex. As research moves forward, the inheritance picture for ASMT may become clearer.
What does my ASMT result mean for my family?
There is not yet a broadly confirmed family inheritance pattern tied to a specific health condition for the ASMT gene. A result in ASMT does not, by itself, give a clear, predictable meaning for close relatives in the way some single-gene conditions do.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for ASMT gene variants reads DNA from a saliva or blood sample and checks the ASMT gene sequence for changes. Labs may study the ASMT gene alone or include it in a larger panel or exome test, and the report classifies any variant as benign, uncertain, or clinically relevant.
When should I consider getting a genetic test?
There is not yet a broadly established ASMT-specific reason for genetic testing in routine care. Testing decisions are usually based on your symptoms and family history, best discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains varies by the condition and the kind of variant present. Over time, the way the body works is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when viewed together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small inherited differences can change how the body absorbs, breaks down, or responds to a drug, so the same treatment may work better for one person than for another. This is common and can influence how much benefit someone feels or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic variation can affect a person’s response to medications. By looking at the relationship between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the ASMT gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response. If you have concerns about side effects, unusual reactions, or whether a medicine is helping, it is best to discuss them with your doctor, who can review your overall health and treatment plan.
History
Interest in the ASMT gene grew out of melatonin research in the mid 20th century, after melatonin was isolated in 1958 and scientists began tracing how the body makes it. The enzyme linked to this gene was first studied under the name hydroxyindole O-methyltransferase, or HIOMT, before the gene was later named ASMT. Early work focused on the pineal gland, where researchers connected day night body rhythms with this biochemical pathway. As medical science evolved, so did understanding of this gene. By the 1990s and 2000s, the ASMT gene had been mapped and described more clearly, and researchers also identified a related ASMTL gene nearby. That history helped place ASMT within the broader story of sleep and circadian biology research.